Related Experiment Video
Updated: Sep 19, 2025
07:50
Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
Published on: July 16, 2012
14.4K
Uncovering Anti-Inflammatory Activity of Ginsenoside Rg1 in a Wound-Inured Zebrafish Model by GC-MS-based Chemical
Su-Jung Hsu1,2, Min He3,4, Luis Francisco Salomé-Abarca5
1Natural Products Laboratory, Institute of Biology, Leiden University, Leiden, Netherlands.
Planta Medica
|June 16, 2025
Summary
Ginsenoside Rg1, a compound from ginseng, effectively reduces inflammation in zebrafish by modulating immune cell activity and metabolism. This suggests Rg1 as a potential therapeutic for inflammatory conditions and immune regulation.
Area of Science:
- Immunology
- Metabolomics
- Pharmacology
Background:
- Cellular metabolic adaptation is crucial for immune responses and can be modulated by bioactive compounds.
- Ginsenoside Rg1, found in ginseng, may act as a glucocorticoid receptor agonist, linking anti-inflammatory effects to metabolic changes.
- Understanding these links can identify metabolic biomarkers for anti-inflammation.
Purpose of the Study:
- To investigate the endogenous metabolic responses to Rg1 and glucocorticoids in vivo.
- To compare the anti-inflammatory effects and metabolic impacts of Rg1 and beclomethasone in zebrafish embryos.
Main Methods:
- Zebrafish embryos were used to assess inflammation and metabolic responses.
- Gas chromatography-mass spectrometry (GC-MS) was employed to analyze primary metabolites.
- Metabolic pathway analysis was performed using the KEGG pathway database.
Main Results:
- Rg1 demonstrated anti-inflammatory effects comparable to beclomethasone in injured zebrafish.
- Rg1 inhibited neutrophil and macrophage migration and modulated pro-inflammatory cytokine gene expression.
- Rg1 altered fatty-acid metabolism and downstream aromatic amino acids in the TCA cycle.
Conclusions:
- Rg1 exhibits significant anti-inflammatory properties in vivo.
- Rg1's anti-inflammatory action involves metabolic reprogramming, particularly in fatty-acid and amino acid pathways.
- Rg1 shows promise as a therapeutic agent for inflammatory diseases and immune regulation.
